Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group.

MLA

Vitale, Alessandro, et al. “Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group.” Journal of Gastrointestinal Surgery, vol. 22, no. 5, May 2018, pp. 859–71. EBSCOhost, https://doi.org/10.1007/s11605-018-3688-y.

APA

Vitale, A., Lai, Q., Farinati, F., Bucci, L., Giannini, E. G., Napoli, L., Ciccarese, F., Rapaccini, G. L., Di Marco, M., Caturelli, E., Zoli, M., Borzio, F., Sacco, R., Cabibbo, G., Virdone, R., Marra, F., Felder, M., Morisco, F., Benvegnù, L., & Gasbarrini, A. (2018). Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group. Journal of Gastrointestinal Surgery, 22(5), 859–871. https://doi.org/10.1007/s11605-018-3688-y

Chicago

Vitale, Alessandro, Quirino Lai, Fabio Farinati, Laura Bucci, Edoardo G. Giannini, Lucia Napoli, Francesca Ciccarese, et al. 2018. “Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group.” Journal of Gastrointestinal Surgery 22 (5): 859–71. doi:10.1007/s11605-018-3688-y.